Shed Weight Loss(Dallas, TX)

诊疗信息

治疗方向
减重与 GLP-1抗衰与长寿激素优化生殖与性功能
常用肽类成分

常见问题

Does this clinic offer telehealth?

Please contact the clinic directly for telehealth availability.

Do they accept HSA/FSA?

Please confirm HSA/FSA acceptance directly with the clinic.

诊所简介

Shed Weight Loss in Dallas, TX offers Semaglutide, Tirzepatide, BPC-157, NAD+, and Kisspeptin-10 peptide therapy with body contouring for medically supervise...

Shed Weight Loss operates a medically supervised weight management clinic in Dallas, TX, combining prescription peptide therapies with body contouring services for patients seeking comprehensive metabolic support. The clinic’s approach centers on GLP-1 receptor agonist protocols using Semaglutide and Tirzepatide, both FDA-approved medications that regulate appetite and insulin response, alongside complementary peptide therapies designed to address recovery, cellular energy, and hormonal balance. Each patient undergoes initial metabolic assessment to determine appropriate medication dosing and treatment combinations based on individual health markers and weight loss objectives.

The peptide menu at Shed Weight Loss extends beyond weight management medications to include BPC-157 for tissue repair and gut health optimization, NAD+ for cellular energy production and metabolic function, and Kisspeptin-10 for reproductive hormone regulation. BPC-157 is frequently incorporated into protocols for patients experiencing digestive issues that may interfere with nutrient absorption or those recovering from injuries that limit physical activity. NAD+ infusions support mitochondrial function and may help address the fatigue that some patients experience during caloric restriction. Kisspeptin-10 therapy addresses hypothalamic-pituitary-gonadal axis function, which can become disrupted during significant weight loss or in patients with pre-existing hormonal imbalances affecting metabolism.

The Dallas clinic provides in-person consultations where medical providers evaluate patient history, current medications, contraindications, and weight loss goals before prescribing peptide protocols. Semaglutide and Tirzepatide programs typically begin with low-dose titration schedules, with patients returning for regular monitoring of weight trends, side effect management, and dosage adjustments. The medical team provides injection training for self-administration of subcutaneous peptides, along with guidance on managing common GLP-1 side effects such as nausea or gastrointestinal changes. Body contouring services are available as adjunctive treatments for patients who have achieved significant weight reduction and are addressing residual aesthetic concerns.

Patients at Shed Weight Loss receive structured protocols that outline expected timelines, monitoring schedules, and criteria for treatment modifications. The clinic’s approach includes nutritional guidance that complements peptide therapy, addressing macronutrient distribution and meal timing to optimize medication effectiveness. Follow-up appointments track progress through body composition analysis and metabolic markers rather than scale weight alone, providing patients with comprehensive data on changes in fat mass, lean tissue, and metabolic health indicators. The medical staff adjusts peptide combinations and dosages based on individual response patterns and any emerging side effects.

Shed Weight Loss serves the Dallas metropolitan area with a focus on patients who have struggled with traditional diet and exercise approaches or those with metabolic conditions such as insulin resistance or prediabetes that complicate weight management. The clinic’s 4.8-star rating across 27 Google reviews reflects patient experiences with the structured medical oversight and multi-modal treatment options. All peptide therapies require in-person evaluation at the Dallas location, where providers can conduct physical examinations, review laboratory work, and ensure appropriate patient selection for prescription medications. The clinic does not offer telehealth consultations, maintaining that initial and ongoing assessments for prescription weight loss medications and peptide therapies require direct provider-patient interaction for safety and efficacy monitoring.

登录

注册

重设密码

请输入您的用户名或电子邮箱地址。您会收到一封包含创建新密码链接的电子邮件。